Summary
Updated Aug 31, 2026
John P. Schmid is Director of BlossomHill Therapeutics, Inc. (BLSM). 11 SEC Form 4 filings on record going back to 2025, most recently on 10 August 2026. Most recent open-market trade: bought $96K of BLSM on 10 August 2026. Lifetime open-market purchases: $96K. Lifetime open-market sales: $1.16M.
Recent Transactions
7Every recent SEC Form 4 transaction John P. Schmid has reported, most recent first.
Trading Pattern
InsiderAlpha's records for John P. Schmid go back to 2025: 11 primary Form 4 filings, an average of 5.5 per year. The typical open-market purchase is $96K (1 buy totaling $96K). The largest single buy on record is $96K of BLSM in 2026. Sales side: 3 recorded sales totaling $1.16M, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies John P. Schmid files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $65.00M of TRAX open-market activity in the last 12 months
- Carl L. Gordon - $10.00M of BLSM open-market activity in the last 12 months
- ORBIMED ADVISORS LLC - $10.00M of BLSM open-market activity in the last 12 months
- Bihua Chen - $5.00M of BLSM open-market activity in the last 12 months
- Daniel Faga - $2.14M of ANAB open-market activity in the last 12 months
- Eric J. Loumeau - $1.32M of ANAB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John P. Schmid?
John P. Schmid is a corporate insider, tracked as Director of BlossomHill Therapeutics, Inc. (BLSM). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John P. Schmid submitted recently?
5 primary Form 4 filings in the last 90 days, covering 4 companies.
Has John P. Schmid been buying or selling stock?
Recorded transactions: 1 open-market purchase ($96K) and 3 open-market sales ($1.16M) across all tracked filings.
Where can I see all of John P. Schmid's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John P. Schmid and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial